Y53F4B.53

Caenorhabditis elegans

Is affected by tatn-1 based on RNA-seq studies.

Y67A10A.342

Caenorhabditis elegans

Is affected by tatn-1 based on RNA-seq studies.

srh-66

Caenorhabditis elegans

Is affected by tatn-1 and clk-1 based on RNA-seq and microarray studies.

tatn-1

Caenorhabditis elegans

Predicted to enable L-tyrosine:2-oxoglutarate aminotransferase activity. Involved in dauer entry. Human ortholog(s) of this gene implicated in tyrosinemia type II. Is an ortholog of human TAT (tyrosine aminotransferase).

srbc-72

Caenorhabditis elegans

Enriched in ASKL based on single-cell RNA-seq studies. Is affected by tatn-1 and clk-1 based on RNA-seq and microarray studies.

cTel7X.1

Caenorhabditis elegans

Is affected by tatn-1; smg-2; and eat-2 based on RNA-seq studies. Is affected by rifampin; allantoin; and Sirolimus based on RNA-seq studies.

C08B6.15

Caenorhabditis elegans

Is affected by several genes including mut-16; ogt-1; and tatn-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

srt-10

Caenorhabditis elegans

Enriched in DVC and PVR based on single-cell RNA-seq studies. Is affected by tatn-1 and etr-1 based on RNA-seq studies. Is affected by resveratrol based on microarray studies.

C36A4.12

Caenorhabditis elegans

Enriched in AVJL; RIM; and RIML based on single-cell RNA-seq studies. Is affected by several genes including etr-1; smg-2; and tatn-1 based on RNA-seq studies. Is affected by Psoralens; allantoin; and rifampin based on RNA-seq studies.

F08F3.6

Caenorhabditis elegans

Expressed in germ line.